Memphis Pharmaceuticals
Last Updated:
- 82.13 EGP
- 3.26
- 4.13%
ممفيس للادوية والصناعات الكيماوية
ممفيس للادوية
Symbol :
MPCI
ISIN :
EGS38351C010
52-Week Range :
23.93
-
84.98
Turnover Ratio :
1.76
Market :
Egyptian Exchange
Sector :
Health Care & Pharmaceuticals
Industry :
Pharmaceuticals and Biotechnology Research & Development
Sub-Industry :
Memphis Pharmaceuticals Announcements
Top News
- A 16-October Memphis Pharmaceutical’s shareholders approve company’s continuity
- B 02-October Memphis Pharmaceutical’s board approves capital raise
- C 14-September Memphis Pharmaceutical approves financing to pay off EGP 300m debt
- D 11-September Memphis Pharmaceutical’s annual profits climb 77%
- E 09-June Memphis Pharmaceutical targets EGP 50m profits in FY22/23
- F 15-March Memphis Pharmaceutical to obtain financing from ADIB
- G 26-January Memphis Pharmaceutical's board approves capital raise to EGP 241m
- H 07-June Essam Sadek named Chairman of Memphis Pharmaceutical
- I 30-May Memphis Pharmaceutical posts 558% higher profits in 10M
- J 21-April Memphis Pharmaceutical's profit hikes 386% in nine months
- K 24-March Memphis Pharmaceutical's pretax profit jumps 480% in eight months
- L 20-January Memphis Pharmaceutical’s pretax profit jumps 463% in H1-20/21
